Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases（2023）
摘要
Ultra-short high-dose PQ was safe and tolerated without severe adverse events. Early treatment was non-inferior to delayed treatment in preventing P. vivax infection at day 42.
更多查看译文
关键词
Malaria,Pediatric,Plasmodium falciparum,Plasmodium vivax,Primaquine,Radical cure,Universal cure
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要